BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24614505)

  • 1. IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.
    Hwang KK; Trama AM; Kozink DM; Chen X; Wiehe K; Cooper AJ; Xia SM; Wang M; Marshall DJ; Whitesides J; Alam M; Tomaras GD; Allen SL; Rai KR; McKeating J; Catera R; Yan XJ; Chu CC; Kelsoe G; Liao HX; Chiorazzi N; Haynes BF
    PLoS One; 2014; 9(3):e90725. PubMed ID: 24614505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL.
    Forconi F; Potter KN; Wheatley I; Darzentas N; Sozzi E; Stamatopoulos K; Mockridge CI; Packham G; Stevenson FK
    Blood; 2010 Jan; 115(1):71-7. PubMed ID: 19887677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells.
    Forconi F; Potter KN; Sozzi E; Henderson I; Cencini E; Rossi D; Bomben R; Gattei V; Gaidano G; Packham G; Stevenson FK
    Blood; 2012 Mar; 119(9):2106-9. PubMed ID: 22234701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural aspects of human IgM antibodies expressed in chronic B lymphocytic leukemia.
    Ramsland PA; Brock CR; Moses J; Robinson BG; Edmundson AB; Raison RL
    Immunotechnology; 1999 Mar; 4(3-4):217-29. PubMed ID: 10231091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL.
    Chang DK; Kurella VB; Biswas S; Avnir Y; Sui J; Wang X; Sun J; Wang Y; Panditrao M; Peterson E; Tallarico A; Fernandes S; Goodall M; Zhu Q; Brown JR; Jefferis R; Marasco WA
    MAbs; 2016; 8(4):787-98. PubMed ID: 26963739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope.
    Que X; Widhopf GF; Amir S; Hartvigsen K; Hansen LF; Woelkers D; Tsimikas S; Binder CJ; Kipps TJ; Witztum JL
    PLoS One; 2013; 8(6):e65203. PubMed ID: 23840319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.
    Hervé M; Xu K; Ng YS; Wardemann H; Albesiano E; Messmer BT; Chiorazzi N; Meffre E
    J Clin Invest; 2005 Jun; 115(6):1636-43. PubMed ID: 15902303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.
    Visco C; Maura F; Tuana G; Agnelli L; Lionetti M; Fabris S; Novella E; Giaretta I; Reda G; Barcellini W; Baldini L; Neri A; Rodeghiero F; Cortelezzi A
    Clin Cancer Res; 2012 Apr; 18(7):1870-8. PubMed ID: 22322667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The
    Perez-Chacon G; Zapata JM
    Front Immunol; 2021; 12():627602. PubMed ID: 33912159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.
    Widhopf GF; Goldberg CJ; Toy TL; Rassenti LZ; Wierda WG; Byrd JC; Keating MJ; Gribben JG; Rai KR; Kipps TJ
    Blood; 2008 Mar; 111(6):3137-44. PubMed ID: 17675554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides that bind specifically to an antibody from a chronic lymphocytic leukemia clone expressing unmutated immunoglobulin variable region genes.
    Liu Y; Higgins CD; Overstreet CM; Rai KR; Chiorazzi N; Lai JR
    Mol Med; 2013 Aug; 19(1):245-52. PubMed ID: 23922242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.
    Lanemo Myhrinder A; Hellqvist E; Sidorova E; Söderberg A; Baxendale H; Dahle C; Willander K; Tobin G; Bäckman E; Söderberg O; Rosenquist R; Hörkkö S; Rosén A
    Blood; 2008 Apr; 111(7):3838-48. PubMed ID: 18223168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
    Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
    Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and genetic basis for development of broadly neutralizing influenza antibodies.
    Lingwood D; McTamney PM; Yassine HM; Whittle JR; Guo X; Boyington JC; Wei CJ; Nabel GJ
    Nature; 2012 Sep; 489(7417):566-70. PubMed ID: 22932267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.
    Chu CC; Catera R; Hatzi K; Yan XJ; Zhang L; Wang XB; Fales HM; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
    Blood; 2008 Dec; 112(13):5122-9. PubMed ID: 18812466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria.
    Trama AM; Moody MA; Alam SM; Jaeger FH; Lockwood B; Parks R; Lloyd KE; Stolarchuk C; Scearce R; Foulger A; Marshall DJ; Whitesides JF; Jeffries TL; Wiehe K; Morris L; Lambson B; Soderberg K; Hwang KK; Tomaras GD; Vandergrift N; Jackson KJL; Roskin KM; Boyd SD; Kepler TB; Liao HX; Haynes BF
    Cell Host Microbe; 2014 Aug; 16(2):215-226. PubMed ID: 25121750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen.
    Steininger C; Widhopf GF; Ghia EM; Morello CS; Vanura K; Sanders R; Spector D; Guiney D; Jäger U; Kipps TJ
    Blood; 2012 Mar; 119(10):2293-301. PubMed ID: 22234695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.